- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03299465
Yoga for Fatigue in the Survivors of Bone Marrow Transplantation
Yoga for Persistent Fatigue in the Survivors of Bone Marrow Transplantation: A Feasibility Study
Study Overview
Detailed Description
OBJECTIVES
Primary Objective: To assess the feasibility of an organized yoga intervention for HCT survivors with CRF.
Hypothesis: A trial of yoga in the HCT survivor population will be deemed feasible if at least 75% of study subjects demonstrated protocol adherence rate of at least 80%.
Secondary Objectives:
- Explore participants' perceptions regarding yoga and physical activity
Hypothesis: HCT survivors will be positive about yoga and will express satisfaction with the yoga program, as will be shown during focus groups that will be held at the end of the yoga program.
- Evaluate the association between yoga practice and self-efficacy and self-regulation
Hypothesis: Adherence to yoga will be associated with higher self-efficacy and selfregulation scores.
- Evaluate the changes in CRF scores from baseline to the end of the yoga program.
Hypothesis: CRF scores at the end of the yoga program will be lower than CRF scores at baseline.
- Evaluate whether changes in CRF are associated with changes in depression, sleep disturbances, physical activity, and pain.
Hypothesis 5: Improvement in CRF will be associated with increased physical activity and decreased depression, sleep disturbances, and pain.
- Evaluate the safety of yoga practice in HCT survivors.
Hypothesis: Yoga will be considered as a safe intervention for CRF in HCT survivors as demonstrated by the absence of adverse events or serious adverse events related to or associated with yoga practice.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48105
- Cancer center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adult HCT survivors as defined by being at least 100 days post autologous or allogeneic transplantation for a malignant disease. There is no restriction to enrollment by donor type, donor cell source, presence or absence of graft versus host disease.
- Age ≥ 18 years at the time of transplant.
- A history of persistent CRF as defined by a perception of general CRF for at least one month before enrollment.
- A history of at least moderate CRF as defined by a CRF score of 4 or more on a 10-point Visual Analog Scale.
- Participants who are deemed qualified for yoga movements according to the Yoga Qualifying Movements Screening Checklist (a checklist developed by researchers at the University of California, Los Angeles to promote yoga safety through assessing the eligibility of each patient)
Exclusion Criteria:
- A self-reported current practice of yoga or any other mind-body therapy, including but not limited to meditation or hypnosis therapy in the past 30 days prior to study enrollment.
- Subjects currently on supplemental oxygen support.
- Subjects currently receiving hemodialysis.
- Subjects currently admitted to an inpatient unit at Michigan Medicine.
- Subjects with an uncontrolled, active infection. Subjects with viremia (Cytomegalovirus or other) may be enrolled, provided they are on active therapy and at the discretion of the treating physician.
- Subjects who have relapsed after their autologous or allogeneic transplant.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Yoga arm
A six-week restorative yoga intervention consisting of a weekly, 60-minute yoga group class led by a certified yoga instructor along with twice-weekly home practice using yoga DVD.
|
This is a single arm study and all participants will be assigned to a six-week restorative yoga intervention.
Restorative yoga sessions will consist of gentle physical poses (asanas), breathing control (pranayama), and relaxation (savasana).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Practice log
Time Frame: Weekly during the six-week intervention period
|
Yoga practice at home will be documented on a log sheet to be filled out by participants at the end of each practice week.
We will check class attendance during the weekly telephone call with the study participants.
We will use a log sheet to document in-class yoga practice and location of the yoga performance.
At the end of the program, the number of yoga practice hours per participant will be tabulated.
This number will be used to evaluate participants' adherence to yoga practice.
|
Weekly during the six-week intervention period
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Side-effects/adverse events log
Time Frame: Weekly during the six-week intervention period
|
All subjects will be asked to complete a Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) weekly.
The PRO-CTCAE questionnaire in this study includes a total of six items (numbness and tingling, dizziness, blurry vision, muscle pain, joint pain, others).
|
Weekly during the six-week intervention period
|
|
Multidimensional Fatigue Symptom Inventory
Time Frame: At baseline (before treatment) and within 10 days of the last in-class yoga session
|
The Multidimensional Fatigue Symptom Inventory-Short Form (MFSISF) will be used to measure fatigue in the past seven days.
The MFSISF includes a total of 30 items that produce five subscales: general fatigue, physical fatigue, emotional fatigue, mental fatigue, and vigor.
All items have a possible score of 0 to 4, 0 representing "not at all" and 4 being "extremely".
|
At baseline (before treatment) and within 10 days of the last in-class yoga session
|
|
PROMIS-SF-Fatigue
Time Frame: At baseline (before treatment) and within 10 days of the last in-class yoga session
|
The PROMIS-SF-Fatigue will be used to measure fatigue in the past seven days.
The PROMIS-SF-fatigue is a unidimensional scale that measures general fatigue.
It contains eight items with a possible score of 1 to 5 for each item.
|
At baseline (before treatment) and within 10 days of the last in-class yoga session
|
|
Brief Pain Inventory - Short Form
Time Frame: At baseline (before treatment) and within 10 days of the last in-class yoga session
|
The Brief Pain Inventory - Short Form (BPISF) will be used to measure pain in the past 24 hours.
The BPISF is a 9-item questionnaire used to evaluate the severity of a participants' pain and the impact of pain on the patient's daily functioning.
|
At baseline (before treatment) and within 10 days of the last in-class yoga session
|
|
PROMIS-SF-depression
Time Frame: At baseline (before treatment) and within 10 days of the last in-class yoga session
|
The PROMIS-SF-depression will be used to measure depression in the past seven days.
The PROMIS-SF-depression contains eight items with a possible score of 1 to 5 for each item (1: never, 5: always).
|
At baseline (before treatment) and within 10 days of the last in-class yoga session
|
|
PROMIS-SF-sleep disturbance
Time Frame: At baseline (before treatment) and within 10 days of the last in-class yoga session
|
The PROMIS-SF-sleep disturbance will be used to measure sleep disturbance in the past seven days.
The PROMIS-SF-sleep disturbance contains eight items with a possible score of 1 to 5 for each item.
|
At baseline (before treatment) and within 10 days of the last in-class yoga session
|
|
Index of Self-Regulation Scale
Time Frame: At baseline (before treatment) and within 10 days of the last in-class yoga session
|
The Index of Self-Regulation Scale (ISR) is designed to measure individuals' level of self-regulation for health behaviors.
The ISR contains nine items that produces three subscales: reconditioning, stimulus control, and behavioral monitoring.
|
At baseline (before treatment) and within 10 days of the last in-class yoga session
|
|
Self-Efficacy for Managing Chronic Disease Scale
Time Frame: At baseline (before treatment) and within 10 days of the last in-class yoga session
|
Self-efficacy will be measured using the Self-Efficacy for Managing Chronic Disease Scale (SEMCD).
The SEMCD contains six items.
Each item has a possible score of 1 to 10 (1: not at all confident, 10: totally confident).
|
At baseline (before treatment) and within 10 days of the last in-class yoga session
|
|
PROMIS-SF- physical function
Time Frame: At baseline (before treatment) and within 10 days of the last in-class yoga session
|
The PROMIS-SF- physical function contains 12 items with a possible score of 1 to 5 for each item (1: unable to do, 5: without any difficulty).
All items are reversely coded.
The total score can range from 12 to 60 with higher scores indicating better physical function.
|
At baseline (before treatment) and within 10 days of the last in-class yoga session
|
|
electronic pedometer
Time Frame: At baseline (before treatment) and within 10 days of the last in-class yoga session
|
The electronic pedometer is an objective measure of physical activity.
It is a simple, unobtrusive device that can be placed on the belt or waistband to count the number of steps taken.
|
At baseline (before treatment) and within 10 days of the last in-class yoga session
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HUM00130548
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer
-
Cellworks Group Inc.RecruitingCancer | Relapsed Cancer | Refractory CancerUnited States
-
University of Michigan Rogel Cancer CenterCompletedCancer Liver | Cancer Brain | Cancer Head &Neck | Cancer PelvisUnited States
-
Yale UniversityNational Institute of Nursing Research (NINR); The Glimpse Group IncRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI); Atrium Health Wake Forest BaptistRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
Vanderbilt-Ingram Cancer CenterEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IV Gastric Cancer | Stage IVA Colorectal Cancer | Stage IVA Pancreatic Cancer | Stage IVB Colorectal Cancer | Stage IVB Pancreatic Cancer | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric... and other conditionsUnited States
-
Second Affiliated Hospital of Soochow UniversityNot yet recruitingCancer | Solid Cancer
-
New Mexico Cancer Research AllianceOhio State University Comprehensive Cancer Center; H. Lee Moffitt Cancer Center...RecruitingCancer | Cancer RiskUnited States
-
Children's Hospital of PhiladelphiaCompletedCancer | Childhood CancerUnited States
-
University of California, San FranciscoBristol-Myers Squibb; PfizerTerminatedStage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Metastatic Colorectal Adenocarcinoma | Metastatic Colon Adenocarcinoma | Metastatic Rectal Adenocarcinoma | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Stage IV Colon Cancer | Stage IV Rectal... and other conditionsUnited States
Clinical Trials on Yoga
-
Universität Duisburg-EssenCompleted
-
Ataturk UniversityKTO Karatay UniversityRecruiting
-
Adiyaman University Research HospitalCompletedDepression | Stress | Anxiety | Psychological ResilienceTurkey
-
NMP Medical Research InstituteYog-Kulam; Department of Zoology, University of Rajasthan, IndiaCompleted
-
NMP Medical Research InstituteWarwick Research Services; Yog-KulamCompleted
-
Northwestern UniversityCompleted
-
University of MinnesotaCompleted
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedDepression | Pain | Breast Cancer | FatigueUnited States
-
Saglik Bilimleri UniversitesiThe Scientific and Technological Research Council of TurkeyCompletedStress | Anxiety | Telerehabilitation | Yoga | University StudentsTurkey
-
Emory UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedProstate CarcinomaUnited States